within Aequorea victoria GFP aa 1-100 (N terminal). The exact sequence is proprietary.
Database link: P42212
On the basis of low sequence homology, ab32146 is predicted to show no or limited cross-reactivity to RFP, YFP, BFP, and CFP
A trial size is available to purchase for this antibody.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab32146 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/20000.
GFP - 27kDa, Proprietary tag/GFP fusion protein - 52kDa
Blocking and dilution buffer: 5% NFDM /TBST.